Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 21, 1997 - Issue 2
39
Views
3
CrossRef citations to date
0
Altmetric
Original Article

HB Osler [β145(HC2)TYRàASP] Results from Posttranslational Modification

, , , , , , , & show all
Pages 109-120 | Received 21 Jun 1996, Accepted 19 Sep 1996, Published online: 07 Jul 2009
 

Abstract

We studied two members of an African American family with eryth-rocytosis. An abnormal hemoglobin variant with an electrophoretic pattern on cellulose acetate similar to Hb J was identified. The oxygen dissociation curve using whole blood was biphasic, dramatically left-shifted, and hyperbolic. Sequence analysis of DNA from the proband showed heterozygosity for a TàA change at the first position of codon 145 in the β-globin gene which results in the substitution of an asparagine residue for normal tyrosine. The second cycle of C-terminal amino acid sequence analysis of a mixture of a- and β-globin chains showed tyrosine, aspartic acid, and small amounts of asparagine. Collectively, these results indicate the existence of a mutation at codon 145 of the β-globin gene which encodes for asparagine instead of tyrosine, and that asparagine then undergoes a partial posttranslational deamidation to aspartic acid. This amino acid substitution corresponds to Hb Osler, which is a high oxygen affinity hemoglobin variant, initially described to be caused by a substitution of TyràAsp at β145. Posttranslational amino acid modification may constitute an important component in the patho-physiology of hemoglobinopathjes.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.